JCP Weekly November 12, 2019

Letter to the Editor

BMI and Remission in Depressed Patients Receiving IV Ketamine

Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between body mass index and ketamine response.

DOI: 10.4088/JCP.19l12852 | Posted: 11/12/2019

See past JCP Weekly